Veristat congratulates Awakn - UK State Funding to Identify Optimal Pathway to Market In UK...
Veristat congratulates Awakn for being awarded UK State Funding to Identify Optimal Pathway to Market In UK & US For Its Lead Clinical...
Posts about
Clinical Trials
Veristat Congratulates Origin Biosciences for FDA Approval
Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry during the Week of Rare Disease Day 2021
Veristat Launches Business Operations in Spain and Names Dr. Montserrat Barceló to Vice...
Leading the Organic and Acquisition Growth of Veristat Operations Throughout Europe
Veristat Named a Top Patient Recruitment Company by PharmaTech Outlook
Delivering A Patient-Centric Approach to Recruitment and Retention for Clinical Trials
SOUTHBOROUGH, MA – December 7, 2020 –Veristat, a...
Veristat Announces Global Cell and Gene Therapy Center of Excellence
Accelerating cell and gene therapy opportunities for patients by advancing access to knowledge and leveraging experience for sponsors to...
Veristat Launches A Flexible Virtual Clinical Trial Solution
Veristat Enhances Patient-Centricity Offering by Delivering Clinical Trials Directly to Patients
SOUTHBOROUGH, MA – September 30, 2020 – ...
Veristat Helps Antibe Therapeutics Complete Their Phase IIB Study During COVID-19
In early 2019, Veristat helped Antibe Therapeutics, a biotech company with a drug platform of game-changing therapeutics in pain and...
Veristat Strengthens Its European Presence with the Acquisition of TCTC
Increasing Its Footprint and Expanding Therapeutic Expertise to Guide Sponsors Throughout the Clinical Development Lifecycle
Veristat Advances Game-Changing Pain and Inflammation Therapy
Veristat continues to support Antibe Therapeutics, a biotech company with a drug platform of game-changing therapeutics in pain and...